Clinical Trial Update: Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and tolerability of ISX (Isoxsuprine HCL) in multiple sclerosis relapses has completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• ISX (Isoxsuprine HCL) (Isoxsuprine HCL)

Snippet

Sponsor: University of New Mexico | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-02-06